TIDES Europe Speakers

Dr. Sergey Tsukanov, PhD

Senior Director Chemistry

Eli Lilly and Company

Dr. Claudia Höbartner, Ph.D.

Professor of Organic Chemistry

University of Würzburg

Jacob Challand Kofoed, PhD

Scientific Director, Peptide Research 1 

Novo Nordisk A/S

Michael Kopach, PhD

Associate Vice President, Synthetic Molecule Design and Development

Eli Lilly and Company

Federico Di Chiaro

Senior CMC Project Manager

Zealand Pharma

El Djouhar Rekaï, PhD

Process & Analytical Development Director at PolyPeptide Group

PolyPeptide Group

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Ashish Sarode, PhD

Director, Delivery & Formulations, mRNA Center of Excellence

Sanofi

Afaf El-Sagheer, PhD

Assistant Professor

University of Southampton

Alaric Desmarchelier, PhD

Business Development Manager - Peptides

Almac Group

Alexander Kleinsmann, PhD

Director R&D, CMC Development

Bachem AG

Ammar Ahmed, PhD

Senior Scientist, Chemical Development

AstraZeneca

Andrea Gargano, PhD

Associate Professor, Analytical Chemistry Group, Van't Hoff Institute for Molecular Science

University of Amsterdam

Anja Beschnitt, PhD

Associate Director Analytical Development

BioNTech SE

Anja Hoeg

Entrepreneur in Residence

SmartRNA

Anne Conibear, BSc(Hons) MSc PhD

Assistant Professor, Peptide and Protein Chemistry

Technische Universität Wien

Armin Delavari, PhD

Senior Scientist, ASO Purification Process Development

Biogen

Asaf Cohen

Head of CMC, N=1 Program

Sheba Medical Center

Audrey Maudhuit

European Director

Fluid Air

Beatriz De La Torre, Ph.D.

Research Professor, Laboratory of Medicine and Med

University Of KwaZulu-Natal

Bhavani Prasad Vinjamuri, Ph.D

Scientist II

Biogen

Brenno Masina

Senior Graduate Student

ETH Zurich

Brian Dooley

Pharmaceutical Quality Senior Specialist

European Medicines Agency

Bruce Morimoto, PhD

Independent Consultant

TIDES Advisor

Carolin Lechner, PhD

Director R&D

Bachem

Chris Chorley

Regulatory Program Director

Roche

Chris Oswald

Founder, Owner, and Principal Consultant

Coswald Consulting LLC

Christa Else

Senior Regulatory Affairs Manager, Technical Regulatory Lead

F. Hoffmann-La Roche Ltd.

Christoph Schmoelzer

Head of Product Management, Advanced Therapies

Thermo Fisher Scientific

Covadonga Paneda, PhD

Chief Development Officer

Altamira Therapeutics

Dr. Daniel Waschke, PhD

Associate Regulatory Program Director

F. Hoffmann-La Roche Ltd.

David Entwistle, Ph.D.

Senior Director, Technical Client Services

Codexis

Eleonora Marino

Pharmaceutical Quality Specialist

European Medicines Agency

Fabien Rousset, PhD

Global Director of Innovation

Polypeptide Group

Fabio Macciardi, MD, PhD

Chief Scientific Officer

Cognigenics

Fernando Albericio, Ph.D

Research Professor

University of Kwazulu-Natal

Florian Mann, PhD

Principal Scientist RNA Delivery & Non-Viral Vector Platform Lead

Bayer AG

Dr Gilles Divita

Founder and CEO

Divincell

Gregoire Menoud

Senior PhD student

EPFL

Hannah Bolt, PhD, MBA

Head of Peptide Discovery

AstraZeneca

Dr. Holger Stalz, PhD

LCMS Product Specialist

Agilent Technologies

Huihe (Julia) Zhu, PhD

Associate Vice President, Innovation & Process Strategy

Nitto Avecia

Jacques Dumas

Chief Scientific Officer

Arrakis Therapeutics

Janik Kaufmann, PhD

Technical Sales Specialist Oligonucleotides

Hongene Biotech Corporation

Jill Caswell, PhD

Biology Team Leader

Almac Sciences

Joan Malmstrom, PhD

Senior Specialist, Analytical Support

Novo Nordisk A/S

Joanna Hemming Taylor, PhD

Associate Principal Scientist

AstraZeneca

John Lopez, PhD

Associate Director Science & Technology

Novartis

John McCafferty, PhD

Chief Technology Officer

Maxion Therapeutics

John-Sigurd Svendsen, PhD

Founder and Chief Scientific Officer

Amicoat

Joshua Brooks, PhD

Senior Director

Alnylam Pharmaceuticals

Judit Tomsen Melero, PhD

Preclinical Project Manager

noctuRNA Therapeutics

Karunakar (Karu) Sukuru, R.Ph., Ph.D

Global Vice President, Pharma Product Development and Head, Scientific Advisory

Catalent

Kieren Mather, MD

Associate VP-Medical-Incretins and Diabetes Breakthroughs, Early Clinical Research

Eli Lilly and Company

Lin Chen, PhD

Associate Vice President, Peptide Manufacturing Technology and R&D

Asymchem

Lluís Riera-Ponsatí, PhD

Director of Preclinical Development

Neumirna Therapeutics

Louis Diorazio, PhD

Senior Principal Scientist, New Modalities

AstraZeneca

Lucas Bethge, Ph.D.

VP, Group Leader Chemistry

Silence Therapeutics

Luis Garcia

Président

SQY Therapeutics

Marc Jacob, PhD

Head of Strategic Development, Chromatography Products

YMC America

Dr Margot Pont, PhD

VP Translational Development

Integra Therapeutics

Mark Eccleston

CEO

ValiRx

Mark Frigerio

Vice President, Head of Platform Technology & Science

Bicycle Therapeutics

Martina Niess

Scientist

F. Hoffmann-La Roche Ltd

Mathias Wendt, PhD

Senior Peptide Chemist

Priavoid GmbH

Mathieu Cinier

Chief Scientific Officer

Affilogic

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Mimoun Ayoub, PhD

Senior VP, Global Head of Peptide and Oligonucleotide Platforms

CordenPharma International

Monika Papayova

EPSRC Doctoral Prize Research Fellow

University of Southampton

Nadya Brady

Founder

LuminaBio Advisory

Nenad Svrzikapa, DPhil

Co-Founder, Head of Oligonucleotide Platform

Orfonyx Bio

Nicolo Zuin Fantoni, PhD

Senior Scientist, Oligonucleotides

F. Hoffmann-La Roche Ltd.

Pachamuthu Kandasamy, PhD

Vice President, Medicinal Chemistry

Wave Life Sciences

Paul Nioi, PhD

SVP

Alnylam Pharmaceuticals, Inc.

Peter Hagedorn

Senior Director, Head of Bioinformatics

Contera Pharma

Poul Sorensen

CEO

Inverna therapeutics

Ralph Koitz

Head of Digital Manufacturing & Data Analytics

Bachem

Dr. Riccardo Bernasconi, Ph.D.

Director Business Development

Bachem

Robert Hagopian

Global Director, Biotech Partnerships

PolyPeptide Group

Robert Place

Chief Technology Officer

MiNA Therapeutics Limited

Shanthi Ganesh

Director

Novo Nordisk

Shubhadra Pillay, PhD

Solutions Product Manager

Bruker BioSpin

Dr. Sonja Merkas, PhD

Founder and CEO

Livinovea

Sophie Corbet

Bioprocessing Technical Service Manager

DuPont

Sriram Sathy, Ph.D.

Chief Scientific Officer

AIRNA

Stefan Hyde

Automation Manager

Asahi Kasei Bioprocess America

Dr. Stefan Lutz, PhD

Chief Scientific Officer

Codexis

Stephanie Coffin

Global Peptide Drug Substance Steward

Eli Lilly

Dr Stephany Standley

Vice President, Oligonucleotide Synthesis and Chemistry

Wave Life Sciences

Steven Wolk, PhD

President

Sinawali Biotechnology Solutions

Thomas Müller-Späth, PhD

CEO

ChromaCon AG

Thomas Rupp

Vice President, CMC Strategy

Axolabs Berlin GmbH

Tobias Kapp, PhD

Global Head of Peptide Development

CordenPharma

Tracey Burr, Ph.D.

Executive Director, CMC Regulatory Affairs

Ionis Pharmaceuticals

Trent Nowak

Senior Research Associate, Manufacturing & Operatiions

Ionis Pharmaceuticals

Troels Koch, PhD

Chief Technology Officer

Cora Biosciences

Victoire Laude

Innovation Scientist

PolyPeptide Laboratories

Wuming Yan

Chief Scientist Oligonucleotides

Asymchem

Yogesh Sanghvi, PhD

President

Rasayan Inc.